Newsroom

 
Archive
Clear Filters
T-Heart appoints Sarah Sorrel as independent board member
t-heart
T-Heart appoints Sarah Sorrel as independent board member
November 29, 2022
T-Heart appoints Sarah Sorrel as independent board member
Clear Filters
BrainEver and 3P Biopharmaceuticals collaborate on development of recombinant human homeoprotein Engrailed-1
brainever
BrainEver and 3P Biopharmaceuticals collaborate on development of recombinant human homeoprotein Engrailed-1
October 13, 2022
BrainEver and 3P Biopharmaceuticals collaborate on development of recombinant human homeoprotein Engrailed-1
Prophesee Showcases the Solutions and Partners Driving Event Based Vision at VISION 2022
prophesee
Prophesee Showcases the Solutions and Partners Driving Event Based Vision at VISION 2022
October 3, 2022
Prophesee Showcases the Solutions and Partners Driving Event Based Vision at VISION 2022
Clear Filters
Prophesee, CIS Announce Partnership to Develop Industry’s First Event-Based Structured Light Eval Kit, Enabling Next-Generation 3D Sensing performance in Machine Vision Cameras
prophesee
Prophesee, CIS Announce Partnership to Develop Industry’s First Event-Based Structured Light Eval Kit, Enabling Next-Generation 3D Sensing performance in Machine Vision Cameras
October 3, 2022
Prophesee, CIS Announce Partnership to Develop Industry’s First Event-Based Structured Light Eval Kit, Enabling Next-Generation 3D Sensing performance in Machine Vision Cameras
Clear Filters
Datalogic begins landmark partnership with Prophesee
prophesee
Datalogic begins landmark partnership with Prophesee
October 3, 2022
Datalogic begins landmark partnership with Prophesee
Chronolife announces collaboration with Garmin to further enrich continuous remote patient monitoring in real-life conditions
chronolife
Chronolife announces collaboration with Garmin to further enrich continuous remote patient monitoring in real-life conditions
September 29, 2022
Chronolife announces collaboration with Garmin to further enrich continuous remote patient monitoring in real-life conditions
Prophesee closes €50M C Series round with new investment from Prosperity7 to drive commercialization of revolutionary neuromorphic vision technology
prophesee
Prophesee closes €50M C Series round with new investment from Prosperity7 to drive commercialization of revolutionary neuromorphic vision technology
September 22, 2022
Prophesee closes €50M C Series round with new investment from Prosperity7 to drive commercialization of revolutionary neuromorphic vision technology